Miss the live town hall? View the on-demand version here as senior leaders from 6 companies discuss how Medical Affairs is functioning during the COVID-19 pandemic, share best practices, and look to the future of MA post-COVID-19. OPEN ACCESS: membership is not required to view.
This article aims to position learning agility as an emergent capability that supports the future-proofing of Medical Affairs strategic planning processes and outputs. In essence, learning agility is a set of skills, competencies, and mindsets that support our capability of “knowing what to do when we don’t know what to do.”
In this APAC Town Hall, senior leaders discuss: Managing Individual Performance Remotely; Virtual Leadership Mindset & Skills; Effective Team Engagement in the Virtual Space; Engagement of KOLs Virtually
This paper provides a brief overview of the results of two MAPS insight surveys as well as suggested next steps to develop a common framework that biopharma companies can use to achieve a more consistent and effective approach to generating medical insights as a principal driver for strategy shaping and choice of tactics.
As a result of the global COVID-19 outbreak, field teams are no longer able to visit HCPs face-to-face. During this Webinar, we will explore the skills and challenges around effective remote engagement and share hints and tips to help you access, engage and follow-up with HCPs remotely.
As we consider the wider changes seen across our communities, we explore how Medical Affairs needs to continue to evolve in how it thinks, acts and engages to drive further improvements in healthcare outcomes, as well as to ensure that our teams are equipped and empowered to adapt and excel in our new reality.
This Webinar demonstrates how to generate insights through digitally-based interactions without directly engaging HCPs. We discuss and share various ways that MSLs can generate insights through digital mechanisms, from attending “live” virtually-broadcast panel sessions to following influential KOLs on Twitter.
Disseminating research data and clinical concepts to the right audience has demonstrated significant value, not only to biopharmaceutical organizations, but across the research and healthcare industries.
Through this course you will recognize terms such as artificial intelligence (AI), machine learning (ML), deep learning, and neural networks to arrive at best decisions and insights needed for success.